pharmaphorum media and Symplur, LLC launch Conference360 Report to help pharma and other stakeholders understand social media conversations around medical congresses
QuintilesIMS’s Cristina Oliva talks to pharmaphorum about her personal highlights from this year’s congress.
Roche’s PD-L1 drug has generated impressive data in second line lung cancer
Despite Keytruda’s overwhelming victory, it’s not over yet in NSCLC
Merck unveils impressive data on Keytruda, trumping BMS’ Opdivo
Commentary on key cancer data from ESMO by Stephanie Hawthorne
Novartis’ phase 3 advanced breast cancer therapy ribociclib shows promise